Works by Januszewicz, E

Results: 25

Hypercalcemia Complicating Myelomonoblastic Transformation of Chronic Myeloid Leukemia.
Published in:
Acta Haematologica, 1988, v. 79, n. 4, p. 211, doi. 10.1159/000205810
By:
- Attar, E.;
- Prokocimer, M.;
- Januszewicz, E.;
- Theodor, E.
Publication type:
Article
A Therapeutic Trial with Low-Dose Cytarabine in Myelodysplastic Syndromes and Acute Leukemia.
Published in:
Acta Haematologica, 1985, v. 73, n. 2, p. 71, doi. 10.1159/000206283
By:
- Inbal, A.;
- Januszewicz, E.;
- Rabinowictz, M.;
- Shaklai, M.
Publication type:
Article
P83 FAs mediate cardiac hypertrophic response to exercise.
Published in:
Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S14, doi. 10.1093/cvr/cvu082.26
By:
- Brix, S;
- Foryst-Ludwig, A;
- Salatzki, J;
- Januszewicz, E;
- Rothe, M;
- Kershaw, E;
- Kintscher, U
Publication type:
Article
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.
Published in:
Bone Marrow Transplantation, 2000, v. 26, n. 9, p. 955, doi. 10.1038/sj.bmt.1702650
By:
- Prince, H M;
- Rischin, D;
- Toner, G C;
- Seymour, J F;
- Blakey, D;
- Gates, P;
- Eerhard, S;
- Chapple, P;
- Quinn, M;
- Brettell, M;
- Juneja, S;
- Wolf, M;
- Januszewicz, E H;
- Richardson, G;
- Scarlett, J;
- Briggs, P
Publication type:
Article
Docetaxel effectively mobilizes peripheral blood CD34<sup>+</sup> cells.
Published in:
Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 483, doi. 10.1038/sj.bmt.1702540
By:
- Prince, H M;
- Toner, G C;
- Seymour, J F;
- Blakey, D;
- Gates, P;
- Eerhard, S;
- Chapple, P;
- Wall, D;
- Quinn, M;
- Juneja, S;
- Wolf, M;
- Januszewicz, E H;
- Richardson, G;
- Scarlett, J;
- Briggs, P;
- Brettell, M;
- Rischin, D
Publication type:
Article
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer.
Published in:
Bone Marrow Transplantation, 1999, v. 23, n. 5, p. 427, doi. 10.1038/sj.bmt.1701606
By:
- Prince, H M;
- Gardyn, J;
- Millward, M J;
- Rischin, D;
- Francis, P;
- Gates, P;
- Chapple, P;
- Quinn, M;
- Juneja, S;
- Wolf, M;
- Januszewicz, E H;
- Richardson, G;
- Scarlett, J;
- Briggs, P;
- Brettell, M;
- Toner, G C
Publication type:
Article
The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders.
Published in:
Cancer (0008543X), 2006, v. 107, n. 4, p. 773, doi. 10.1002/cncr.22022
By:
- Polizzotto, Mark N.;
- Tam, Constantine S.;
- Milner, Alvin;
- Januszewicz, E. Henry;
- Prince, H. Miles;
- Westerman, David;
- Wolf, Max M.;
- Seymour, John F.
Publication type:
Article
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma.
Published in:
Cancer (0008543X), 2006, v. 106, n. 11, p. 2412
By:
- Constantine S. Tam;
- Max Wolf;
- H. Miles Prince;
- E. Henry Januszewicz;
- David Westerman;
- Katherine I. Lin;
- Dennis Carney;
- John F. Seymour
Publication type:
Article
A new model for predicting infectious complications during fludarabine‐based combination chemotherapy among patients with indolent lymphoid malignancies.
Published in:
Cancer (0008543X), 2004, v. 101, n. 9, p. 2042
By:
- Constantine S. Tam;
- Max M. Wolf;
- E. Henry Januszewicz;
- Andrew P. Grigg;
- H. Miles Prince;
- David Westerman;
- John F. Seymour
Publication type:
Article
Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.
Published in:
Cancer (0008543X), 2004, v. 100, n. 10, p. 2181
By:
- Constantine S. Tam;
- Max M. Wolf;
- E. Henry Januszewicz;
- H. Miles Prince;
- David Westerman;
- John F. Seymour
Publication type:
Article
Fludarabine combinations for patients with advanced marginal zone lymphomas – best treatment option or too toxic?
Published in:
2009
By:
- Peinert, Stefan;
- Carney, Dennis;
- Miles Prince, H.;
- Henry Januszewicz, E.;
- Seymour, John F.
Publication type:
Letter
Emergence of central nervous system myeloma in the era of novel agents.
Published in:
Hematological Oncology, 2012, v. 30, n. 4, p. 170, doi. 10.1002/hon.1021
By:
- Gangatharan, Shane A;
- Carney, Dennis A;
- Prince, H Miles;
- Wolf, Max M;
- Januszewicz, E Henry;
- Ritchie, David S;
- Harrison, Simon J
Publication type:
Article
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
Published in:
Leukemia (08876924), 2010, v. 24, n. 12, p. 2056, doi. 10.1038/leu.2010.218
By:
- Carney, D. A.;
- Westerman, D. A.;
- Tam, C. S.;
- Milner, A.;
- Prince, H. M.;
- Kenealy, M.;
- Wolf, M.;
- Januszewicz, E. H.;
- Ritchie, D.;
- Came, N.;
- Seymour, J. F.
Publication type:
Article
Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine.
Published in:
2004
By:
- Morgan, S. J.;
- Seymour, J. F.;
- Grigg, A.;
- Matthews, J. P.;
- Prince, H. M.;
- Wolf, M. M.;
- Januszewicz, E. H.
Publication type:
Letter
Hodgkin's disease type Richter's syndrome in chronic lymphocytic leukemia.
Published in:
1999
By:
- Juneja, S;
- Carney, D;
- Ellis, D;
- Januszewicz, E H;
- Wolf, M;
- Prince, H M
Publication type:
Case Study
Requirements for growth of human erythroid progenitors in nutrient agar.
Published in:
American Journal of Hematology, 1983, v. 15, n. 3, p. 207, doi. 10.1002/ajh.2830150302
By:
- Januszewicz, E.;
- Cooper, I. A.;
- Bradley, T. R.
Publication type:
Article
High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience.
Published in:
Internal Medicine Journal, 2001, v. 31, n. 5, p. 279, doi. 10.1046/j.1445-5994.2001.00066.x
By:
- Dowling, A. J.;
- Prince, H. M.;
- Wirth, A.;
- Wolf, M.;
- Januszewicz, E. H.;
- Juneja, S.;
- Seymour, J. F.;
- Gates, P.;
- Smith, J. G.
Publication type:
Article
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.
Published in:
Leukemia & Lymphoma, 2016, v. 57, n. 5, p. 1044, doi. 10.3109/10428194.2015.1096353
By:
- Lew, Thomas E.;
- Cheah, Chan Y.;
- Carney, Dennis A.;
- Prince, H. Miles;
- Wolf, Max;
- Bazargan, Ali;
- Januszewicz, E. Henry;
- Filshie, Robin;
- Westerman, David;
- Seymour, John F.;
- Tam, Constantine S.
Publication type:
Article
Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.
Published in:
Leukemia & Lymphoma, 2010, v. 51, n. 12, p. 2188, doi. 10.3109/10428194.2010.524326
By:
- Peinert, Stefan;
- Tam, Constantine S.;
- Prince, H. Miles;
- Scarlett, John;
- Wolf, Max M.;
- Januszewicz, E. Henry;
- Westerman, David;
- Seymour, John F.
Publication type:
Article
Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older.
Published in:
Leukemia & Lymphoma, 2005, v. 46, n. 11, p. 1575, doi. 10.1080/10428190500235884
By:
- Mileshkin, L. R.;
- Seymour, J. F.;
- Wolf, M. M.;
- Gates, P.;
- Januszewicz, E. H.;
- Joyce, P.;
- Prince, H. M.
Publication type:
Article
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.
Published in:
British Journal of Cancer, 2014, v. 111, n. 6, p. 1072, doi. 10.1038/bjc.2014.405
By:
- Cheah, C Y;
- Herbert, K E;
- O'Rourke, K;
- Kennedy, G A;
- George, A;
- Fedele, P L;
- Gilbertson, M;
- Tan, S Y;
- Ritchie, D S;
- Opat, S S;
- Prince, H M;
- Dickinson, M;
- Burbury, K;
- Wolf, M;
- Januszewicz, E H;
- Tam, C S;
- Westerman, D A;
- Carney, D A;
- Harrison, S J;
- Seymour, J F
Publication type:
Article
Inhibition of normal human macrophage progenitors by retinoic acid.
Published in:
British Journal of Haematology, 1984, v. 58, n. 1, p. 119, doi. 10.1111/j.1365-2141.1984.tb06066.x
By:
- Januszewicz, E.;
- Cooper, I. A.
Publication type:
Article
A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma.
Published in:
2005
By:
- Hönemann, Dirk;
- Prince, H. Miles;
- Seymour, John F.;
- Wolf, Max M.;
- Westerman, David;
- Januszewicz, E. Henry
Publication type:
Letter
Fludarabine Combination Therapy Is Highly Effective in First-Line and Salvage Treatment of Patients with Waldenström's Macroglobulinemia.
Published in:
Clinical Lymphoma & Myeloma, 2005, v. 6, n. 2, p. 136
By:
- Tam, Constantine S.;
- Wolf, Max M.;
- Westerman, David;
- Januszewicz, E. Henry;
- Prince, H. Miles;
- Seymour, John F.
Publication type:
Article
High‐dose chemotherapy with busulphan and cyclophosphamide and bone‐marrow transplantation for drug‐sensitive malignancies in adults: a preliminary report.
Published in:
Medical Journal of Australia, 1989, v. 151, n. 7, p. 379, doi. 10.5694/j.1326-5377.1989.tb101219.x
By:
- Sheridan, William P.;
- Boyd, Andrew W.;
- Green, Michael D.;
- Russell, David M.R.;
- Thomas, Robert J.S.;
- McGrath, Katherine M.;
- Vaughan, Stephen L.;
- Scarlett, John D.;
- Griffiths, James D.;
- Brodie, Graeme N.;
- Januszewicz, E. Henry;
- Fox, Richard M.
Publication type:
Article